Markets:

Overview

News

Currencies

International

Treasuries

Seelos Therapeutics, Inc. - Common Stock (NQ:SEEL)

1.280 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 15, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Seelos Therapeutics, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Mid-Afternoon Market Update: Dow Gains 150 Points; Red Cat Holdings Shares Spike Higher ↗

September 27, 2021

Toward the end of trading Monday, the Dow traded up 0.43% to 34,949.08 while the NASDAQ fell 0.35% to 14,995.27. The S&P also fell, dropping 0.05% to 4,453.40. The U.S. has...

Via Benzinga

Topics Stocks

Why Seelos Therapeutics Stock Is Trading Higher Today ↗

September 27, 2021

Seelos Therapeutics Inc (NASDAQ:SEEl) is trading higher Monday after Roth Capital analyst Jonathan Aschoff upgraded the stock from Neutral to Buy and raised the price...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 27, 2021

Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. Keros Therapeutics's stock is trading at a volume...

Via Benzinga

31 Stocks Moving In Monday's Mid-Day Session ↗

September 27, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 ↗

September 27, 2021

Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ:

Via Benzinga

Seelos Therapeutics Shares Gain On FDA Approval To Add SLS-005 Regimen In HEALEY ALS Trial ↗

September 21, 2021

The Sean M. Healey & AMG Center for ALS at Mass General received approval from the FDA and the Mass General Brigham Institutional Review Board to add SLS-005 (...

Via Benzinga

Why Seelos Therapeutics' Stock Is Trading Higher Today ↗

September 21, 2021

Seelos Therapeutics (NASDAQ:SEEL) shares are trading higher. Traders are circulating a Massachusetts General Hospital report titled 'Investigational drug SLS-005 (...

Via Benzinga

$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins

September 15, 2021

Via FinancialNewsMedia

Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry? ↗

September 09, 2021

By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...

Via Benzinga

Psychedelic Drug Industry Report Card For 2021 ↗

September 01, 2021

In assessing the psychedelic drug industry, a primary focus for investors is drug development.

Via Talk Markets

25 Stocks Moving in Monday's Pre-Market Session ↗

August 23, 2021

Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X...

Via Benzinga

Which Psychedelic Drug Stock Category Outperformed Last Week ↗

August 10, 2021

Which has performed best YTD, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Via Talk Markets

Topics Cannabis

Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance" ↗

July 23, 2021

Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector. On Friday,

Via Benzinga

Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness

July 21, 2021

Via FinancialNewsMedia

Topics Law Enforcement

How To Invest In "Magic Mushrooms" (Psychedelics) ↗

July 09, 2021

A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest.

Via Talk Markets

Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies ↗

July 07, 2021

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps...

Via Benzinga

Seelos' Single Dose Of SLS-004 Shows Reduction In Parkinson's Associated mRNA, Protein Expression ↗

July 07, 2021

Seelos Therapeutics Inc (NASDAQ: SEEL) has announced positive in vivo data demonstrating down-regulation of SNCA mRNA and protein expression from a study of SLS-...

Via Benzinga

The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend ↗

July 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 06, 2021

Gainers Opiant Pharmaceuticals (NASDAQ:OPNT

Via Benzinga

Why Seelos Therapeutics Is Moving Today ↗

July 01, 2021

Seelos Therapeutics, Inc. (NASDAQ: SEEL) shares are trading higher after Guggenheim analyst Yatin Suneja initiated coverage on the stock with a Buy rating and announced an $8...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021 ↗

July 01, 2021

Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 01, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE) shares moved upwards by 60.76% to $2.09 during Thursday's pre-market session. The market value of their outstanding shares...

Via Benzinga

Why Seelos Therapeutics Stock Is Jumping Today ↗

June 01, 2021

The company has been included in the first U.S. psychedelics-focused ETF.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021 ↗

June 01, 2021

Upgrades For Equity Residential (NYSE:EQR), BMO Capital upgraded the previous rating of Market Perform to Outperform. Equity Residential earned $0.68 in the first quarter...

Via Benzinga

Seelos's Amyotrophic Lateral Sclerosis Candidate, SLS-005 An Orphan Drug In Europe ↗

May 27, 2021

Seelos Therapeutics Inc's (NASDAQ: SEEL) Trehalose (SLS-005) has received Orphan Drug Designation for amyotrophic lateral sclerosis (ALS) from the European...

Via Benzinga

Psyched: MindMed To Begin Mescaline Trials and Deepak Chopra Partnership, Seelos And Cybin Advance Clinical Research ↗

May 24, 2021

MindMed’s News Spree: Mescaline Trials, Chopra Foundation Partnership and LSD Research MindMed (NASDAQ:

Via Benzinga

Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment

May 20, 2021

Via FinancialNewsMedia

Topics Death

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 20, 2021

Gainers VistaGen Therapeutics (NASDAQ:VTGN) shares moved upwards by 14.34% to $2.63 during Thursday's pre-market session. The market value of their outstanding shares...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 19, 2021

Gainers VistaGen Therapeutics (NASDAQ:VTGN

Via Benzinga

CNS Pharmaceuticals Commences Patient Enrollment in Potentially Pivotal Study of Berubicin ↗

May 19, 2021

CNS Pharmaceuticals today announced open enrollment for its potentially pivotal study evaluating the efficacy and safety of Berubicin in the treatment of recurrent GBM.

Via Talk Markets

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.